Peripheral immune signatures and survival in stage IV melanoma

被引：0
|
作者：
Pawelec, Graham P. [1 ]
Martens, Alexander [1 ]
Garbe, Claus [1 ]
Weide, Benjamin [1 ]
Derhovanessian, Evelyna [1 ]
Schadendorf, Dirk [2 ]
Di Giacomo, Anna Maria [3 ]
Maio, Michele [3 ]
de Vries, Jolanda [4 ]
Zelba, Henning [1 ]
机构：
[1] Univ Tubingen, Tubingen, Germany
[2] Univ Essen Gesamthsch, Essen, Germany
[3] Univ Siena, I-53100 Siena, Italy
[4] Univ Nijmegen, Nijmegen, Netherlands
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-2547
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2547
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Stage-IV Melanoma and Pulmonary Metastases: Factors Predictive of Survival
    Heather B. Neuman
    Ami Patel
    Christine Hanlon
    Jedd D. Wolchok
    Alan N. Houghton
    Daniel G. Coit
    Annals of Surgical Oncology, 2007, 14 : 2847 - 2853
  • [22] Clinical predictors of survival in real world practice in stage IV melanoma
    Hu, Hsien-Pang
    Archer, Christine
    Yip, Desmond
    Peters, Geoffrey
    CANCER REPORTS, 2023, 6 (02)
  • [23] Clinical predictors of survival in real world practice in stage IV melanoma
    Hu, Hsien-Pang
    Archer, Christine
    Yip, Desmond
    Peters, Geoffrey
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 181 - 182
  • [24] Stage-IV melanoma and pulmonary metastases: Factors predictive of survival
    Neuman, Heather B.
    Patel, Ami
    Hanlon, Christine
    Wolchok, Jedd D.
    Houghton, Alan N.
    Coit, Daniel G.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (10) : 2847 - 2853
  • [25] Improved survival for stage IV melanoma from an unknown primary site
    Lee, C. C.
    Faries, M. B.
    Wanek, L. A.
    Morton, D. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients
    Mactier, Swetlana
    Kaufman, Kimberley L.
    Wang, Penghao
    Crossett, Ben
    Pupo, Gulietta M.
    Kohnke, Philippa L.
    Thompson, John F.
    Scolyer, Richard A.
    Yang, Jean Y.
    Mann, Graham J.
    Christopherson, Richard I.
    PIGMENT CELL & MELANOMA RESEARCH, 2014, 27 (06) : 1106 - 1116
  • [27] Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast Cancer
    Wistuba-Hamprecht, Kilian
    Gouttefangeas, Cecile
    Weide, Benjamin
    Pawelec, Graham
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [28] TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma
    Hsueh, EC
    Gupta, RK
    Qi, K
    Yee, R
    Leopoldo, ZC
    Morton, DL
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1997, 3 (06): : 364 - 370
  • [29] Interpreting the Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma
    Uno, Hajime
    Kim, Dae Hyun
    Wei, Lee-Jen
    JAMA ONCOLOGY, 2018, 4 (08) : 1135 - 1136
  • [30] pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy
    Jansen, Philipp
    Galetzka, Wolfgang
    Thielmann, Carl M.
    Murali, Rajmohan
    Zaremba, Anne
    Standl, Fabian
    Lodde, Georg
    Moeller, Inga
    Sucker, Antje
    Paschen, Annette
    Hadaschik, Eva
    Ugurel, Selma
    Zimmer, Lisa
    Livingstone, Elisabeth
    Schadendorf, Dirk
    Stang, Andreas
    Griewank, Klaus G.
    EUROPEAN JOURNAL OF CANCER, 2025, 220
12345